# Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus

> **NCT01408199** · PHASE4 · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 15 (actual)

## Conditions studied

- Cutaneous Lupus

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT01408199
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-08
- **Final completion:** 2011-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2011-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408199, "Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01408199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*